We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

69 hedge funds and large institutions have $4.17M invested in Tvardi Therapeutics in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.21% less ownership

Funds ownership: 0.9% → 0.69% (-0.21%)

9% less capital invested

Capital invested by funds: $4.56M → $4.17M (-$394K)

13% less funds holding

Funds holding: 79 → 69 (-10)

56% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 16

85% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 34

Holders
69
Holders Change
-10
Holders Change %
-12.66%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
34
Closed
16
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$14K

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$30.8K
2
Renaissance Technologies
Renaissance Technologies
New York
+$14.1K
3
FWCM
Ferguson Wellman Capital Management
Oregon
+$11.3K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.7K
5
C
Certuity
Florida
+$4.13K

Top Sellers

Rank Fund Capital Flow
1
DGI
Disciplined Growth Investors
Minnesota
-$268K
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$161K
3
YIH
Y-Intercept (HK)
Hong Kong
-$107K
4
Jane Street
Jane Street
New York
-$105K
5
Goldman Sachs
Goldman Sachs
New York
-$101K
Name Holding Trade Value Shares
Change 		Change in
Stake
WWP
51
WR Wealth Planners
Missouri
$230 +$246 +21 New
ME
52
McIlrath & Eck
Washington
$227 – – –
AF
53
Allworth Financial
California
$222 – – –
HI
54
Harbour Investments
Wisconsin
$162 – – –
BWP
55
Baldwin Wealth Partners
Massachusetts
$154 -$973 -83 -86%
FCA
56
FinTrust Capital Advisors
South Carolina
$81 – – –
PPA
57
Painted Porch Advisors
California
$77 +$82 +7 New
CFD
58
Creative Financial Designs
Indiana
$68 – – –
TC
59
Truvestments Capital
Florida
$54 +$59 +5 New
SPIA
60
Steward Partners Investment Advisory
New York
$46 – – –
SIS
61
Sound Income Strategies
Florida
$31 – – –
CFGS
62
Concourse Financial Group Securities
Alabama
$30 – – –
FRA
63
Front Row Advisors
California
$25 – – –
Comerica Bank
64
Comerica Bank
Texas
$12 – – –
CPG
65
Cornerstone Planning Group
New Jersey
$11 – – –
US Bancorp
66
US Bancorp
Minnesota
$11 – – –
DFA
67
DHJJ Financial Advisors
Illinois
$1 – – –
PA
68
Parallel Advisors
California
$1 – – –
YIH
69
Y-Intercept (HK)
Hong Kong
– -$107K -11,520 Closed
Goldman Sachs
70
Goldman Sachs
New York
– -$101K -10,824 Closed
Charles Schwab
71
Charles Schwab
California
– -$57.6K -6,200 Closed
HF
72
HRT Financial
New York
– -$42K -4,547 Closed
CC
73
Centiva Capital
New York
– -$25K -2,689 Closed
PP
74
Paloma Partners
Connecticut
– -$14.2K -1,528 Closed
Citadel Advisors
75
Citadel Advisors
Florida
– -$11.8K -1,266 Closed
1 2
3
4

TVRD Hedge Fund Activity: Q3 2024 in Review

69 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q3 2024, worth a combined $4.17M — down 8.6% from $4.56M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of TVRD and 7 opened new positions — a net loss of 9 holders — while 34 trimmed existing stakes and 5 added.

The largest buyer was XTX Topco, opening a new position worth an estimated $30.8K. The largest seller was Disciplined Growth Investors, cutting an estimated $268K.

  • 69 institutional investors held Tvardi Therapeutics (TVRD) as of Q3 2024, down from 79 in Q2 2024.
  • Funds reported $4.17M of Tvardi Therapeutics stock for Q3 2024, down 8.6% quarter-over-quarter.
  • 7 funds opened new Tvardi Therapeutics positions in Q3 2024 and 16 closed out, a net change of -9 holders.
  • The largest Tvardi Therapeutics buyer in Q3 2024 was XTX Topco, an estimated $30.8K added.
  • The largest Tvardi Therapeutics seller in Q3 2024 was Disciplined Growth Investors, an estimated $268K sold.

Based on aggregated 13F filings for Q3 2024.